Icariin inhibits inflammation via immunomodulation of the cutaneous hypothalamus-pituitary-adrenal axis in vitro

Clinical and Experimental Dermatology
L KongJ Dong

Abstract

Dysfunction of skin steroidogenesis plays an important role in inflammatory skin diseases. We previously carried out an animal study which showed that icariin could inhibit the inflammation of atopic dermatitis by regulating the cutaneous hypothalamus-pituitary-adrenal axis (HPAA). To explore the immunomodulation of icariin on cutaneous HPAA by detecting the response to the inflammatory cytokines tumour necrosis factor-α/interferon-γ in HaCaT cells. Cortisol level and the steroidogenesis-regulating enzymes CYP11A1 and CYP11B1 were measured to evaluate the level of skin steroidogenesis. In addition, the therapeutic effects of blocking CRH-R1 by the CRH-R1 inhibitor antalarmin and blocking the CRH-R1/2 signal pathway by the nonspecific CRH receptor antagonist astressin were observed. Unexpectedly, we found that icariin treatment blocked the secretion of the inflammatory cytokines and prevented initiation of steroidogenesis; however, prolonged treatment with icariin significantly increased steroidogenesis in HaCaT cells. The promoting effect of icariin on steroidogenesis was not dependent on the CRH-R1 pathway. Icariin has a regulatory effect on steroidogenesis in HaCaT cells, which may provide a promising therapeutic target for t...Continue Reading

References

Jun 1, 1990·The Journal of Investigative Dermatology·J AnselS Hefeneider
Jul 1, 1996·The Journal of Clinical Endocrinology and Metabolism·A SlominskiM Mihm
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·K P KaralisJ A Majzoub
Sep 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Angelika Buske-KirschbaumDirk Hellhammer
Jul 15, 2004·Psychological Bulletin·Suzanne C Segerstrom, Gregory E Miller
Feb 7, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·B E Leonard
May 10, 2006·Clinical and Experimental Dermatology·G W M Millington
Jul 21, 2006·Annals of the New York Academy of Sciences·M S HarbuzD S Jessop
Mar 27, 2010·Immunopharmacology and Immunotoxicology·Jinfeng WuJingcheng Dong
Nov 26, 2010·Biochemical and Biophysical Research Communications·Rosalind F HannenMichael P Philpott
Jan 18, 2011·The Journal of Biological Chemistry·Sasa VukelicMarjana Tomic-Canic
Feb 26, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Andrzej SlominskiRobert C Tuckey
Aug 14, 2013·Endocrine Reviews·Andrzej T SlominskiJean Rivier
Nov 1, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jianhua HuangShijin Xia
Jun 4, 2014·Experimental Dermatology·Andrzej T SlominskiRobert C Tuckey
Jul 7, 2015·Experimental Gerontology·Su-Qin ZhangZi-Yin Shen
Apr 12, 2016·Journal of Cellular Physiology·Justyna M WierzbickaAndrzej T Slominski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.